Literature DB >> 29958712

Echocardiography in Patients With Infective Endocarditis and the Impact of Diagnostic Delays on Clinical Outcomes.

William J Young1, Daniel A Jeffery2, Alina Hua2, Chris Primus2, Robert Serafino Wani3, Satya Das3, Kit Wong4, Rakesh Uppal4, Martin Thomas2, Ceri Davies2, Guy Lloyd1, Simon Woldman2, Sanjeev Bhattacharyya5.   

Abstract

Infective endocarditis (IE) is associated with high mortality and morbidity. The aim of this study was to investigate the impact of timing of echocardiography on IE complications. We studied 151 consecutive patients with definite IE. Valve destruction was defined as ≥1 of severe regurgitation, cardiac abscess, or fistula. A definitive echocardiogram was the first echocardiogram (transthoracic (TTE) or Transesophageal (TEE)) which identified pathology consistent with IE and further echocardiography was not required for the diagnosis. TTE and TEE were performed within 4 days of admission in 62% and 15% patients respectively. Definitive echocardiography was achieved with TTE in 60% patients and required additional TEE in 40% patients. Significantly more in-patient embolic events occurred when definitive echocardiography was performed late (≥4 days) compared with early (<4 days) (40% vs 14%, p = 0.043). A significantly greater proportion of patients who underwent late definitive echocardiography (≥4 days) required valve surgery (73% vs 56%, p = 0.04). Time to definitive echocardiography (odds ratio [OR] 1.015, p = 0.011), male gender (OR 1.254, p = 0.005) and age (OR 0.992, p = 0.002) were predictors of severe valve destruction. Late definitive echocardiography (OR 1.166, p=0.035) was a predictor of in-patient embolism. In conclusion, time to definitive echocardiography is an important predictor of valve destruction, embolic events, and subsequent valve surgery. Pathways to reduce delays to echocardiography are required in patients with suspected IE.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2018        PMID: 29958712     DOI: 10.1016/j.amjcard.2018.04.039

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  An appraisal of clinical practice guidelines for the appropriate use of echocardiography for adult infective endocarditis-the timing and mode of assessment (TTE or TEE).

Authors:  Peihan Xie; Xiaodong Zhuang; Menghui Liu; Shaozhao Zhang; Jia Liu; Donghong Liu; Xinxue Liao
Journal:  BMC Infect Dis       Date:  2021-01-21       Impact factor: 3.090

Review 2.  Infective endocarditis complicated by embolic events: Pathogenesis and predictors.

Authors:  Wangling Hu; Xindi Wang; Guanhua Su
Journal:  Clin Cardiol       Date:  2021-02-01       Impact factor: 3.287

3.  The Epidemiology of Endocarditis in Manitoba: A Retrospective Study.

Authors:  Duncan J Maguire; Rakesh C Arora; Brett M Hiebert; Brenden Dufault; Mullein D Thorleifson
Journal:  CJC Open       Date:  2021-07-29

4.  Association between Wait Time for Transthoracic Echocardiography and 28-Day Mortality in Patients with Septic Shock: A Cohort Study.

Authors:  Jiezhao Zheng; Qilin Yang; Tianyu Kong; Xiaohua Chen; Rundong Wang; Jiaxian Huo; Weichao Huang; Deliang Wen; Xuming Xiong; Zhenhui Zhang
Journal:  J Clin Med       Date:  2022-07-16       Impact factor: 4.964

5.  Risk stratification biomarkers for Staphylococcus aureus bacteraemia.

Authors:  Yi Cao; Alessander O Guimaraes; Melicent C Peck; Oleg Mayba; Felicia Ruffin; Kyu Hong; Montserrat Carrasco-Triguero; Vance G Fowler; Stacey A Maskarinec; Carrie M Rosenberger
Journal:  Clin Transl Immunology       Date:  2020-02-13

6.  Recurrent strokes in an occult case of recurrent Cutibacterium acnes prosthetic valve infective endocarditis: a case report.

Authors:  Charles Fry; Christopher P Primus; Robert Serafino-Wani; Simon Woldman
Journal:  Eur Heart J Case Rep       Date:  2021-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.